Shao, L., Kahraman, N., Yan, G., Wang, J., Ozpolat, B., & Ittmann, M. (2019). Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer. Prostate.
Citação norma ChicagoShao, Longjiang, Nermin Kahraman, Ge Yan, Jianghua Wang, Bulent Ozpolat, and Michael Ittmann. "Targeting the TMPRSS2/ERG Fusion MRNA Using Liposomal Nanovectors Enhances Docetaxel Treatment in Prostate Cancer." Prostate 2019.
ציטוט MLAShao, Longjiang, et al. "Targeting the TMPRSS2/ERG Fusion MRNA Using Liposomal Nanovectors Enhances Docetaxel Treatment in Prostate Cancer." Prostate 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.